Global Drug Discovery Informatics Market 2026-2030

Global Drug Discovery Informatics Market 2026-2030

The global drug discovery informatics market is forecasted to grow by USD 6027.4 mn during 2025-2030, accelerating at a CAGR of 12.5% during the forecast period. The report on the global drug discovery informatics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for data-driven drug discovery, advancements in computational biology, expanding pharmaceutical and biotechnology pipelines and outsourcing trends.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data. For further information on this report, please visit -

https://www.technavio.com/report/report/drug-discovery-informatics-market-industry-analysis

Technavio's global drug discovery informatics market is segmented as below:

By Application

• Discovery informatics
• Development informatics

By Solution

• Software
• Services

By End-User

• Pharma and biotech companies
• Contract research organizations
• Academic and research institutes

Geography

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of ai and ml into informatics platforms as one of the prime reasons driving the global drug discovery informatics market growth during the next few years. Also, growing adoption of cloud-based drug discovery informatics solutions and increased focus on integrated end-to-end discovery informatics platforms will lead to sizable demand in the market.

The report on the global drug discovery informatics market covers the following areas:

• Global drug discovery informatics market sizing
• Global drug discovery informatics market forecast
• Global drug discovery informatics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global drug discovery informatics market vendors that include Accenture PLC, Certara Inc., Charles River Laboratories, Collaborative Drug Discovery, Cresset Biomolecular Ltd., Curia Global Inc., Dassault Systemes SE, Dotmatics, Eurofins Scientific SE, Evotec SE, IBM Corp., Jubilant Pharmova Ltd., LabVantage Solutions Inc., OpenEye Scientific, Revvity Inc., Schrodinger Inc., Selvita SA, Thermo Fisher Scientific Inc.. Also, the global drug discovery informatics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth. Show more